share_log

Fusion Pharmaceuticals, BWXT Medical Announce Actinium-225 Partnership To Scale Supply For Developing Targeted Alpha Therapies

Fusion Pharmaceuticals, BWXT Medical Announce Actinium-225 Partnership To Scale Supply For Developing Targeted Alpha Therapies

Fusion PharmPharmticals和BWXT Medical宣布建立Actdium-225合作伙伴关系,为开发靶向阿尔法疗法扩大供应
Benzinga Real-time News ·  2023/01/05 17:04

Fusion Pharmaceuticals, BWXT Medical Announce Actinium-225 Partnership To Scale Supply For Developing Targeted Alpha Therapies

Fusion PharmPharmticals和BWXT Medical宣布建立Actdium-225合作伙伴关系,为开发靶向阿尔法疗法扩大供应

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发